Saudi Society of Clinical Pharmacy

Member

Pharmacotherapy Update in Critically Ill Patients with COVID-19 – WEBINAR

The Saudi Society of Clinical Pharmacy (SSCP) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education
  Critical Care and Emergency Medicine PSN and Infectious Disease PSN are happy to announce that registration for our webinar titled: “Pharmacotherapy Update in Critically Ill Patients with COVID-19” is now open! The conference will allow all healthcare professionals to meet and share their knowledge.
3 August 2021 (18:50 – 22:30) 3 CME accredited by SCFHS and ACPE Target Audience: Pharmacist Fees: Free-Registration  
Speaker Name Activity name Objectives Activity Universal Number
Dr. Khalid Al Sulaiman, BSc. Pharm, SSC-PhP,SCC-CCP, BCCCP, BCNSP, MBA Anticoagulation in COVID19 Critically ill patients -To describe and discuss the epidemiology, pathophysiology, risk factors and coagulation abnormalities that occur with COVID19. -To differentiate between COVID19 induced coagulopathy (CIC) and Disseminated intravascular coagulation (DIC). -To construct a therapeutic plan for patients with COVID19 to prevent and treat thrombosis, including choice of agent(s), dosage, dose adjustment and monitoring of pharmacologic intervention. 0662-0000-21-016-L01-P
P. Brandon Bookstaver, PharmD, FCCP, FIDSA Antimicrobial stewardship in the era of COVID-1 Discuss changes in workflow and resources allocated to antimicrobial stewardship during COVID-19 pandemic   Describe the prevalence of bacterial co-infection in COVID-19 infection   Describe changes in institutional antibiotic utilization amidst the COVID-19 pandemic 0662-0000-21-017-L01-P
Lama H Nazer, PharmD, BCPS, FCCM King Hussein Cancer Center Corticosteroids in COVID, To Give or Not to Give! To evaluate the efficacy of corticosteroids in the treatment of patients with COVID. To identify patients who may benefit from treatment with corticosteroids. To determine the most appropriate corticosteroid and appropriate dosing regimen for patients with COVID. 0662-0000-21-018-L01-P
Ahmad Jamal Mahrous, Pharm.D. Clinical Pharmacist Specialist, Infectious Diseases Assistant Professor, Clinical Pharmacy Department College of Pharmacy, Umm Al-Qura University COVID-19 Antiviral- Update on current pharmacotherapy management of COVID-patients in the ICU -Identify emerging treatment strategies for SARS-CoV-2 -Summarize evidence for the use of antiviral pharmacologic therapies in the treatmentof COVID-19 patient in the ICU -Differentiate between guideline recommendations for the use of antivirals in thetreatment of COVID-19 0662-0000-21-019-L01-P
Andrea Nei, PharmD, BCPS, BCCCP; Mayo Clinic Hospital – Rochester, Rochester, MN Navigating the Pendulum Swing: Sedation and Analgesia in Patients with COVID-19 -Identify the role of non-conventional sedative agents for mechanically ventilated patients with COVID-19 -Review an approach to identification and management of iatrogenic withdrawal from sedative and analgesic agents 0662-0000-21-020-L01-P
    Awarding of credit requirement: To obtain a certificate of continuing education, you must submit a completed evaluation form and pass the post-activity assessment (60 % correct answers) within 2 weeks of attending an activity The credit will be automatically uploaded in your CPE monitor account within 60 days. Registration  bit.ly/3iQcTv3    
Share the Post: